2m 2m 2m 2m 2m 2m 2m
SURROZEN (SRZN)
NASDAQ
$22.86+$0.05 (+0.21%)
Price as of Jul 14, 2026 7:00 AM EDT- $264.8MMarket Cap
- 164.92%1-Year Change
- BiotechnologyIndustry
SURROZEN (SRZN)
$22.86+$0.05 (+0.21%)
SRZN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $22.81 | ||
Change | -$0.38 (-1.64%) | ||
Open | $23.19 | ||
High | $23.70 | ||
Low | $21.54 | ||
Previous Close | $23.19 | ||
Volume | 336,596 | ||
30-Day Average Volume | 195,742 | ||
1-Week Change | -3.59% | ||
1-Month Change | -2.48% | ||
1-Year Change | 164.92% | ||
3-Year Change | 115.67% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 11.6M | ||
Total Assets | $120.7M | ||
Market Cap | $264.8M | ||
Enterprise Value | $157.9M | ||
Period: QTR TTM FY | |||
Revenue | $5.0M | ||
Net Income | -$127.5M | ||
Free Cash Flow | -$12.6M | ||
EBIT | -$127.5M | ||
EBITDA | -$127.4M | ||
Net Working Capital | $104.4M | ||
EPS | -$11.65 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 32 | ||
P/B | -1 | ||
P/E | -2 | ||
PEG | -0 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 12/14/2023 | ||
Earnings & Revenue